H. Yue

478 total citations
15 papers, 374 citations indexed

About

H. Yue is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, H. Yue has authored 15 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in H. Yue's work include Retinal Diseases and Treatments (2 papers), Retinal Imaging and Analysis (2 papers) and Otitis Media and Relapsing Polychondritis (2 papers). H. Yue is often cited by papers focused on Retinal Diseases and Treatments (2 papers), Retinal Imaging and Analysis (2 papers) and Otitis Media and Relapsing Polychondritis (2 papers). H. Yue collaborates with scholars based in United States, China and United Kingdom. H. Yue's co-authors include Michael Ruvolo, Lyle J. Arnold, Mark A. Reynolds, Ilsa M. Coleman, Zora Modrušan, Lin Bai, Pirow Bekker, Thomas J. Schall, Leal Herlitz and Andrew S. Bomback and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Food Chemistry.

In The Last Decade

H. Yue

13 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Yue United States 7 269 41 31 30 25 15 374
Robert S. Topping United States 8 286 1.1× 22 0.5× 35 1.1× 22 0.7× 19 0.8× 8 381
Jeffrey O. Henderson United States 10 351 1.3× 39 1.0× 45 1.5× 37 1.2× 31 1.2× 22 446
Indi P. Joore Netherlands 4 282 1.0× 75 1.8× 25 0.8× 92 3.1× 27 1.1× 5 416
Michael Malasky United States 8 125 0.5× 39 1.0× 54 1.7× 57 1.9× 52 2.1× 8 301
Rick D. Edmondson United States 8 284 1.1× 24 0.6× 31 1.0× 41 1.4× 10 0.4× 12 366
Jianxun Han Canada 8 183 0.7× 36 0.9× 80 2.6× 96 3.2× 49 2.0× 18 335
Agnieszka Pastuła Germany 8 252 0.9× 58 1.4× 63 2.0× 96 3.2× 39 1.6× 12 425
Elizabeth R. Macari United States 8 217 0.8× 30 0.7× 37 1.2× 26 0.9× 18 0.7× 15 434
Amanda Ernlund United States 11 328 1.2× 19 0.5× 37 1.2× 50 1.7× 39 1.6× 17 408
Maolin Ge China 9 146 0.5× 32 0.8× 45 1.5× 32 1.1× 49 2.0× 19 240

Countries citing papers authored by H. Yue

Since Specialization
Citations

This map shows the geographic impact of H. Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Yue more than expected).

Fields of papers citing papers by H. Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Yue. The network helps show where H. Yue may publish in the future.

Co-authorship network of co-authors of H. Yue

This figure shows the co-authorship network connecting the top 25 collaborators of H. Yue. A scholar is included among the top collaborators of H. Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Yue. H. Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Yao, Lingyun, Qing Huang, Huatian Wang, et al.. (2025). Unlocking novel biopeptides hidden in Camellia seed cake fermented by Bacillus subtilis through in silico and cellular model approaches. Food Chemistry. 476. 143342–143342. 1 indexed citations
4.
Li, Zihe, Lei Zhu, Jun Ma, et al.. (2024). High-quality sika deer omics data and integrative analysis reveal genic and cellular regulation of antler regeneration. Genome Research. 35(1). 188–201. 1 indexed citations
5.
Yue, H. & Lin Bai. (2023). Progress, implications, and challenges in using humanized immune system mice in CAR‐T therapy—Application evaluation and improvement. SHILAP Revista de lepidopterología. 7(1). 3–11. 9 indexed citations
6.
7.
Bomback, Andrew S., et al.. (2022). POS-112 EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON COMPLEMENT 3 GLOMERULOPATHY HISTOLOGIC INDEX OF DISEASE CHRONICITY. Kidney International Reports. 7(2). S47–S48. 17 indexed citations
8.
Merkel, Peter A., David Jayne, H. Yue, et al.. (2020). OP0011 A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY OF AVACOPAN IN ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS. Annals of the Rheumatic Diseases. 79. 8–8. 7 indexed citations
9.
Wainberg, Zev A., John H. Strickler, Michael S. Gordon, et al.. (2018). Phase 1b open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABT-165 plus FOLFIRI in patients with second-line (2L) colorectal cancer (CRC). Annals of Oncology. 29. v66–v66. 4 indexed citations
10.
Strickler, John H., D. Ross Camidge, Rebecca S. Heist, et al.. (2017). MA 02.10 Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC. Journal of Thoracic Oncology. 12(11). S1805–S1806. 8 indexed citations
11.
Sekulić, Aleksandar, Anthony E. Oro, Karl D. Lewis, et al.. (2012). Efficacy and Safety of the Hedgehog Pathway Inhibitor Vismodegib in Patients with Advanced Basal Cell Carcinoma (BCC): 12-Month Erivance BCC Study Update. Annals of Oncology. 23. ix362–ix362. 9 indexed citations
12.
Ho, Allen C., H. Yue, & Laura Wilson. (2008). Ranibizumab in Wet Age-Related Macular Degeneration (AMD): Crossover/ Rollover Patient Results in PIER Study. Investigative Ophthalmology & Visual Science. 49(13). 268–268. 3 indexed citations
13.
Brown, Diane, et al.. (2007). Ranibizumab (Lucentis) in Neovascular Age-Related Macular Degeneration (AMD): Subgroup Analysis of Year 1 PIER Efficacy Data. 48(13). 4540–4540. 3 indexed citations
14.
Yue, H.. (2001). An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Research. 29(8). 41e–41. 246 indexed citations
15.
Modrušan, Zora, Michael Ruvolo, Ilsa M. Coleman, et al.. (2001). Optimized T7 Amplification System for Microarray Analysis. BioTechniques. 31(4). 874–879. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert S. Topping Breakdown of academic impact, for papers by Jeffrey O. Henderson Breakdown of academic impact, for papers by Indi P. Joore Breakdown of academic impact, for papers by Michael Malasky Breakdown of academic impact, for papers by Rick D. Edmondson Breakdown of academic impact, for papers by Jianxun Han Breakdown of academic impact, for papers by Agnieszka Pastuła Breakdown of academic impact, for papers by Elizabeth R. Macari Breakdown of academic impact, for papers by Amanda Ernlund Breakdown of academic impact, for papers by Maolin Ge
Rankless by CCL
2026